Clinical Trials
109 trialsNEST3
City of Hope Medical Center
OPTICAL
Sun Yat-sen University
Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
BACCHUS
University Hospital, Lille
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Case Comprehensive Cancer Center
OPTICAL-3
Sun Yat-sen University
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Alliance for Clinical Trials in Oncology
CRC-ORGA2
University Hospital, Grenoble
BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
Northwestern University
SUNRISE
AdventHealth Translational Research Institute
TTBF
University of California, San Francisco
OvAR-Y
Washington University School of Medicine
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers
Peking University
D3/CME
Haraldsplass Deaconess Hospital
Adaptive Symptom Self-Management Immunotherapy Study
University of Arizona
STARLING
Indiana University
Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases
Dana-Farber Cancer Institute
CIEMAR
Cardiovascular and Interventional Radiological Society of Europe
Brodalumab in the Treatment of Immune-Related Adverse Events
Columbia University
DICHIMIO
University Hospital, Rouen
CrEATE
UMC Utrecht
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Kestrel Therapeutics, Inc.
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
University of Michigan Rogel Cancer Center
Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas
University of California, Irvine
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Alliance for Clinical Trials in Oncology
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
U-TRANS
Gustave Roussy, Cancer Campus, Grand Paris
FORTE
NRG Oncology
Single-stapled Double Purse-string Technique for Colorectal Anastomosis
Vejle Hospital
CIRCULATE-US
NRG Oncology
NACho
Duke University
Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing
Unity Health Toronto
iCaRe2
University of Nebraska
The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer
M.D. Anderson Cancer Center
Study on the Prediction of Regional Lymph Node Metastasis in Colorectal Cancer by Spectral CT Combined With MSI
Yunnan Cancer Hospital
Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer
Massachusetts General Hospital
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
Colorectal Cancer Screening Outreach
Yale University
ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial
University of Aarhus
GERSOM
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Clinicopathological Characteristics of Colon Cancer in Young Age
Seoul National University Bundang Hospital
Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer.
Shandong Cancer Hospital and Institute
DEMETRA
San Raffaele University
Cancer Awareness Among Syrian Migrants
Toros University
Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study
Sun Yat-sen University
EMOTION
Centre Antoine Lacassagne
ACBC
Skane University Hospital
UMC-Colprep
University Medical Center Ho Chi Minh City (UMC)
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
Virginia Commonwealth University